Insights into cardiovascular involvement in patients with Cogan's syndrome.
Lentini
Salvatore
S
Murè
Paola
P
Perrotta
Sossio
S
D000328:Adult; D019917:Blood Vessel Prosthesis Implantation; D002317:Cardiovascular Agents / Q000627:therapeutic use; D055952:Cogan Syndrome / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D003131:Combined Modality Therapy; D001026:Coronary Artery Bypass; D054059:Coronary Occlusion / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008944:Mitral Valve Insufficiency / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D020551:Pulse Therapy, Drug; D016896:Treatment Outcome
D002317:Cardiovascular Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide